BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21269262)

  • 1. The adenine nucleotide translocase 2, a mitochondrial target for anticancer biotherapy.
    Sharaf el dein O; Mayola E; Chopineau J; Brenner C
    Curr Drug Targets; 2011 Jun; 12(6):894-901. PubMed ID: 21269262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitization by knockdown of adenine nucleotide translocase-2.
    Le Bras M; Borgne-Sanchez A; Touat Z; El Dein OS; Deniaud A; Maillier E; Lecellier G; Rebouillat D; Lemaire C; Kroemer G; Jacotot E; Brenner C
    Cancer Res; 2006 Sep; 66(18):9143-52. PubMed ID: 16982757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenine nucleotide translocator: a new potential chemotherapeutic target.
    Belzacq AS; Brenner C
    Curr Drug Targets; 2003 Oct; 4(7):517-24. PubMed ID: 14535652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism.
    Chevrollier A; Loiseau D; Reynier P; Stepien G
    Biochim Biophys Acta; 2011 Jun; 1807(6):562-7. PubMed ID: 20950584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells.
    Gallerne C; Touat Z; Chen ZX; Martel C; Mayola E; Sharaf el dein O; Buron N; Le Bras M; Jacotot E; Borgne-Sanchez A; Lemoine A; Lemaire C; Pervaiz S; Brenner C
    Int J Biochem Cell Biol; 2010 May; 42(5):623-9. PubMed ID: 20060930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP/ADP Turnover and Import of Glycolytic ATP into Mitochondria in Cancer Cells Is Independent of the Adenine Nucleotide Translocator.
    Maldonado EN; DeHart DN; Patnaik J; Klatt SC; Gooz MB; Lemasters JJ
    J Biol Chem; 2016 Sep; 291(37):19642-50. PubMed ID: 27458020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Peptide TP4 Targets Mitochondrial Adenine Nucleotide Translocator 2.
    Su BC; Liu YC; Ting CH; Lyu PC; Chen JY
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32784874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is the specific role of ANT2 in cancer cells?].
    Chevrollier A; Loiseau D; Stepien G
    Med Sci (Paris); 2005 Feb; 21(2):156-61. PubMed ID: 15691486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437.
    Belzacq AS; El Hamel C; Vieira HL; Cohen I; Haouzi D; Métivier D; Marchetti P; Brenner C; Kroemer G
    Oncogene; 2001 Nov; 20(52):7579-87. PubMed ID: 11753636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis.
    Queiroga CS; Almeida AS; Martel C; Brenner C; Alves PM; Vieira HL
    J Biol Chem; 2010 May; 285(22):17077-88. PubMed ID: 20348099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator.
    Vieira HL; Haouzi D; El Hamel C; Jacotot E; Belzacq AS; Brenner C; Kroemer G
    Cell Death Differ; 2000 Dec; 7(12):1146-54. PubMed ID: 11175251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenine nucleotide translocase family: four isoforms for apoptosis modulation in cancer.
    Brenner C; Subramaniam K; Pertuiset C; Pervaiz S
    Oncogene; 2011 Feb; 30(8):883-95. PubMed ID: 21076465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis.
    Verrier F; Deniaud A; Lebras M; Métivier D; Kroemer G; Mignotte B; Jan G; Brenner C
    Oncogene; 2004 Oct; 23(49):8049-64. PubMed ID: 15377997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 and Bax modulate adenine nucleotide translocase activity.
    Belzacq AS; Vieira HL; Verrier F; Vandecasteele G; Cohen I; Prévost MC; Larquet E; Pariselli F; Petit PX; Kahn A; Rizzuto R; Brenner C; Kroemer G
    Cancer Res; 2003 Jan; 63(2):541-6. PubMed ID: 12543814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANT2 isoform required for cancer cell glycolysis.
    Chevrollier A; Loiseau D; Chabi B; Renier G; Douay O; Malthièry Y; Stepien G
    J Bioenerg Biomembr; 2005 Oct; 37(5):307-16. PubMed ID: 16341775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cells.
    Yang Z; Cheng W; Hong L; Chen W; Wang Y; Lin S; Han J; Zhou H; Gu J
    Mol Biol Cell; 2007 Nov; 18(11):4681-9. PubMed ID: 17855512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial adenine nucleotide transporters in myogenesis.
    Flierl A; Schriner SE; Hancock S; Coskun PE; Wallace DC
    Free Radic Biol Med; 2022 Aug; 188():312-327. PubMed ID: 35714845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria.
    Moro L; Arbini AA; Hsieh JT; Ford J; Simpson ER; Hajibeigi A; Oz OK
    Endocrinology; 2010 Apr; 151(4):1643-52. PubMed ID: 20194728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria as therapeutic targets for the treatment of malignant disease.
    Fulda S; Kroemer G
    Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.